T 1089/11 (Serum-free medium/BAVARIAN NORDIC) of 12.12.2017

European Case Law Identifier: ECLI:EP:BA:2017:T108911.20171212
Date of decision: 12 December 2017
Case number: T 1089/11
Application number: 03766057.8
IPC class: C12N 5/0735
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 636 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: METHOD FOR THE AMPLIFICATION OF A POXVIRUS UNDER SERUM FREE CONDITIONS
Applicant name: Bavarian Nordic A/S
Opponent name: Emergent Product Development UK Limited
Sanofi Pasteur
Transgene S.A.
Board: 3.3.08
Headnote: -
Relevant legal provisions:
European Patent Convention 1973 Art 54(3)
European Patent Convention 1973 Art 54(4)
European Patent Convention Art 56
European Patent Convention Art 83
European Patent Convention Art 84
European Patent Convention Art 87
European Patent Convention Art 113(1)
European Patent Convention Art 123(2)
European Patent Convention Art 123(3)
Rules of procedure of the Boards of Appeal Art 12(4)
Keywords: Admission of documents (68) and (69) - (no)
Added matter - (no)
Clarity - (yes)
Sufficiency of disclosure - (yes)
Priority - (yes)
Novelty - (yes)
Inventive step - (yes)
Catchwords:

-

Cited decisions:
T 0023/86
T 0939/92
T 0006/01
T 0235/04
T 1599/06
T 0824/07
Citing decisions:
-

13 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Case Law Book: II Conditions to be met by an Application

General Case Law